Toray TRY-003D – Analysis by EarlyGuard™ miRNA from Women Referred for Additional Testing Due to Abnormal Breast Imaging Classified as Bl-RADS® of 3, 4, or 5 (Toray TRY-003D)

Study Details

This protocol describes a simple, non-significant risk (NSR) clinical study, in which a single 5.0 – 10.0 mL sample of whole blood is drawn from each enrolled Subject meeting requirements of one of the three Study arms. NCT number
Not Applicable

Principal Investigators

  • Suzanne Rose, PhD
Toray International America, Inc.
Ian Goff at 203-358-8879


  • Bennett Cancer Center
    One Hospital Plaza
    Stamford, CT 06902
    Main: 203-276-2695
There is no panel matching the key "Cookie-Notification"